Skip to content

Intracorporeal Anastomosis Versus Extracorporeal Anastomosis for Left Colon Cancer

A Multicenter Randomized Clinical Trial Comparing Surgical Site Infection After Intracorporeal Anastomosis and Extracorporeal Anastomosis for Left Colon Cancer (STARS)

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04201717
Enrollment
350
Registered
2019-12-17
Start date
2021-01-27
Completion date
2029-07-03
Last updated
2025-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer

Keywords

total laparoscopic, laparoscopic assisted, intracorporeal anastomosis, extracorporeal anastomosis

Brief summary

This study aims to investigate the effects of intracorporeal anastomosis and extracorporeal anastomosis in laparoscopic-assisted radical left hemicolectomy on surgical site infection. Also consider perioperative recovery, safety, and oncology outcomes.

Detailed description

This is a prospective, randomized controlled trial. In this trial, cases in the intracorporeal anastomosis group and the extracorporeal anastomosis group are allocated at a 1:1 ratio among patients undergoing laparoscopic radical left hemicolectomy. The peri-operative recovery data, complications, oncology outcomes, and survival are compared.

Interventions

PROCEDURElaparoscopic assisted left colectomy (extracorporeal anastomosis group)

For patients in the control group, the surgeon uses wound edge protectors to exteriorize the colon through a small incision in the midline of the abdomen. A ruler and methylene blue solution are employed to mark the area for colon resection. This guarantees a 10-cm margin from the tumor. Guided by these markers, the marginal vessels and mesentery are divided outside the body. The method of anastomosis is at the surgeon's discretion. A side-to-side anastomosis (including antiperistaltic, isoperistaltic, or overlapping anastomosis) is recommended. Side-to-end or end-to-end anastomosis (sewn by hand or by inserting a circular stapler through the anus or proximal colon) is also allowed. After completing the anastomosis, the incision is sutured. An abdominal drainage tube is inserted at the end of the operation.

PROCEDUREtotal laparoscopic left colectomy (intracorporeal anastomosis group)

In the experimental group, the surgeon will use a 10-cm medical suture and methylene blue solution to mark the resection margin. The marginal vessels and mesentery will be divided inside the body. The proximal and distal colons are resected using a 60mm linear laparoscopic stapler. Side-to-side intracorporeal anastomotic techniques like anti-peristaltic, iso-peristaltic, or overlap methods will be applied. Once the anastomosis is completed, the specimen is retrieved. The surgeon can place the specimen in a sterile plastic bag for retrieval. Alternatively, the surgeon can use a disposable incision retraction fixator to protect the wound. An abdominal drainage tube is inserted.

Sponsors

Jilin University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The clinical surgeons, outcome assessors, data recorders, and statisticians will all operate independently. Due to the nature of the surgical interventions, the surgeons will not be blinded to treatment allocation. However, the outcomes assessor who assess or analyze the end point will be blinded. The patients will also be blinded to group allocation to reduce the risk of bias. Unblinding will not be performed unless the finalization of the main data analysis or required for patient's safety. After the data analysis, we will have a blinded interpretation of the study results to minimize misleading data interpretation.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. age between 18 and 80 years; 2. histologically or cytologically confirmed left-sided colon cancer (distal transverse colon, left colic flexure, descending colon, or proximal sigmoid colon); 3. clinical stage T1-4a, N0-2, and M0; 4. Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2; 5. suitable for laparoscopic colectomy; 6. no previous systemic chemotherapy or radiotherapy; 7. willing to provide written informed consent and comply with the research procedures.

Exclusion criteria

1. Have a history of malignant colorectal tumor or have metastatic or multiple carcinoma. 2. Patients with intestinal obstruction, intestinal perforation, intestinal bleeding, etc. who need emergency surgery. 3. Patients who need to undergo combined organ resection or robot-assisted colectomy. 4. Patients who are receiving preoperative neoadjuvant therapy. 5. ASA grade ≥ IV and/or ECOG performance status score \> 2. 6. Cardiopulmonary dysfunction (NYHA cardiac function classification II-IV), liver dysfunction (MELD score greater than 12), or kidney dysfunction (serum creatinine above the upper limit of normal); 7. Patients with severe psychiatric illness. 8. Pregnant or lactating women. 9. Patients who have a history of taking hormonal drugs. 10. Diabetic patients whose blood sugar cannot be controlled to be within 6.1 - 8.3 mmol/L. 11. Patients with other clinical and laboratory conditions that are considered by researchers as inappropriate for participating in this trial. Exit criteria 1. Patients with other non-tumor diseases that prevent them from continuing to receive this treatment regimen. 2. Patients who need emergency surgical resection due to intestinal obstruction, intestinal perforation, intestinal bleeding, etc. after being enrolled in the study. 3. Patients with distant metastasis confirmed by intraoperative exploration or postoperative pathology, including liver, pelvic cavity, ovary, peritoneum, distant lymph node metastasis, etc. 4. Patients who need combined organ resection as determined by intraoperative exploration. 5. Patients who request to withdraw from this study cohort for various reasons after being enrolled in the study, or who cannot complete the study plan and follow-up for various reasons.

Design outcomes

Primary

MeasureTime frameDescription
The Count of Participants With Surgical Site Infection (SSI)one month after surgeryThe primary outcome was the incidence of SSI based on the Definitions of CDC guidelines: superficial incisional, deep incisional, and organ/space infections . Infections involving both organ/space and the incisional site (superficial or deep) were categorized as organ/space infections. Surgeons and nurses assessed the presence of infection daily during hospitalization. After hospital discharge, all patients were followed up until 30 days after surgery at outpatient clinics to check the wound.

Secondary

MeasureTime frameDescription
The Rate of Conversion to Open Surgeryone hour after surgeryIt is defined as an abdominal incision larger than that necessary for specimen extraction.
the Blood Lossone hour after surgeryIt is defined as the blood loss during operation and is measured in milliliters.
the Operating Timeone hour after surgeryIt is defined as the period from cutting the skin to suturing the skin or doing enterostomy. It is measured in minutes
Completeness of Specimensone hour after surgeryIt is evaluated according to the West classification. The resected specimens will be classified into three groups according to the plane of dissection: mesocolic plane, intramesocolic plane, and muscularis propria plane.
Number of Lymph Nodes Dissectedone week after surgeryThe number of lymph nodes in the mesentery will be calculated. Additionally, the metastatic lymph nodes will be counted.
First Defecation Timeone week after surgerytime to first defecate, measured in days.
the Incidence of Complicationsone month after surgeryIt includes fever of unknown origin, bowel obstruction, anastomotic leakage, SSI, other incisional complications, respiratory complications, urinary complications, cardiovascular and cerebrovascular complications, diarrhea, chylous fistula, intraperitoneal hemorrhage, digestive hemorrhage, gastroparesis, and others (including bacteremia, cholecystitis, ion discharge, pancreatitis, and mental and behavioral abnormalities). Complications are graded according to the Clavien-Dindo classification.
Visual Analogue Scale/Score (VAS)2 days after surgeryPain severity was assessed 48 hours after the operation using a ruler about 10 cm long. The ruler is numbered from 0 to 10. 0-3 points indicate no to mild pain. 4-6 points represent moderate pain. 7-10 points stand for severe pain.
3-year DFS (Disease-free Survival)three years after the operationDFS was defined as the time from randomization until the discovery of local recurrence, distant metastasis, or death from the tumor.
5-year OS (Overall Survival)five years after the operationOS was defined as the time from randomization to death due to any cause.
First Time for Fluid Dietone week after surgerytime to start food intake, measured in days
Postoperative Hospital Stayone month after surgeryThe length of hospital stay after surgery.
the Incision Lengthone hour after surgeryThe incision length is measured with an aseptic ruler at the end of the surgery, after the incision is sutured. It is measured in millimeters.

Countries

China

Participant flow

Participants by arm

ArmCount
Total Laparoscopic Left Colectomy (Intracorporeal Anastomosis Group)
All patients underwent laparoscopic dissection according to the left hemicolon cancer resection standard. lymph nodes and blood vessels, are completely trimmed and resected in an en bloc fashion. Mesentery resection is performed under laparoscopy, and anastomosis is completed under laparoscopy. A small incision is made to extract the specimen after the anastomosis is completed. total laparoscopic left colectomy (intracorporeal anastomosis group): In the experimental group, the surgeon will use a 10-cm medical suture and methylene blue solution to mark the resection margin. The marginal vessels and mesentery will be divided inside the body. The proximal and distal colons are resected using a 60mm linear laparoscopic stapler. Side-to-side intracorporeal anastomotic techniques like anti-peristaltic, iso-peristaltic, or overlap methods will be applied. Once the anastomosis is completed, the specimen is retrieved. The surgeon can place the specimen in a sterile plastic bag for retrieval. Alternatively, the surgeon can use a disposable incision retraction fixator to protect the wound. An abdominal drainage tube is inserted.
157
Laparoscopic Assisted Left Colectomy (Extracorporeal Anastomosis Group)
All patients underwent laparoscopic dissection according to the left hemicolon cancer resection standard. lymph nodes and blood vessels, are completely trimmed and resected in an en bloc fashion. A small incision is made in the middle of the abdomen to trim the mesentery, remove the specimen, and complete the anastomosis. After completing the anastomosis, the incision will be sutured. laparoscopic assisted left colectomy (extracorporeal anastomosis group): For patients in the control group, the surgeon uses wound edge protectors to exteriorize the colon through a small incision in the midline of the abdomen. A ruler and methylene blue solution are employed to mark the area for colon resection. This guarantees a 10-cm margin from the tumor. Guided by these markers, the marginal vessels and mesentery are divided outside the body. The method of anastomosis is at the surgeon's discretion. A side-to-side anastomosis (including antiperistaltic, isoperistaltic, or overlapping anastomosis) is recommended. Side-to-end or end-to-end anastomosis (sewn by hand or by inserting a circular stapler through the anus or proximal colon) is also allowed. After completing the anastomosis, the incision is sutured. An abdominal drainage tube is inserted at the end of the operation.
159
Total316

Baseline characteristics

CharacteristicTotal Laparoscopic Left Colectomy (Intracorporeal Anastomosis Group)Laparoscopic Assisted Left Colectomy (Extracorporeal Anastomosis Group)Total
Age, Continuous62 years61 years61 years
bmi24.5 kg/m^224.8 kg/m^224.6 kg/m^2
Race/Ethnicity, Customized
Asian
157 Participants159 Participants316 Participants
Sex: Female, Male
Female
45 Participants52 Participants97 Participants
Sex: Female, Male
Male
112 Participants107 Participants219 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1570 / 159
other
Total, other adverse events
13 / 15724 / 159
serious
Total, serious adverse events
10 / 1576 / 159

Outcome results

Primary

The Count of Participants With Surgical Site Infection (SSI)

The primary outcome was the incidence of SSI based on the Definitions of CDC guidelines: superficial incisional, deep incisional, and organ/space infections . Infections involving both organ/space and the incisional site (superficial or deep) were categorized as organ/space infections. Surgeons and nurses assessed the presence of infection daily during hospitalization. After hospital discharge, all patients were followed up until 30 days after surgery at outpatient clinics to check the wound.

Time frame: one month after surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Total Laparoscopic Left Colectomy (Intracorporeal Anastomosis Group)The Count of Participants With Surgical Site Infection (SSI)15 Participants
Laparoscopic Assisted Left Colectomy (Extracorporeal Anastomosis Group)The Count of Participants With Surgical Site Infection (SSI)20 Participants
Secondary

3-year DFS (Disease-free Survival)

DFS was defined as the time from randomization until the discovery of local recurrence, distant metastasis, or death from the tumor.

Time frame: three years after the operation

Secondary

5-year OS (Overall Survival)

OS was defined as the time from randomization to death due to any cause.

Time frame: five years after the operation

Secondary

Completeness of Specimens

It is evaluated according to the West classification. The resected specimens will be classified into three groups according to the plane of dissection: mesocolic plane, intramesocolic plane, and muscularis propria plane.

Time frame: one hour after surgery

Secondary

First Defecation Time

time to first defecate, measured in days.

Time frame: one week after surgery

Secondary

First Time for Fluid Diet

time to start food intake, measured in days

Time frame: one week after surgery

Secondary

Number of Lymph Nodes Dissected

The number of lymph nodes in the mesentery will be calculated. Additionally, the metastatic lymph nodes will be counted.

Time frame: one week after surgery

Secondary

Postoperative Hospital Stay

The length of hospital stay after surgery.

Time frame: one month after surgery

Secondary

the Blood Loss

It is defined as the blood loss during operation and is measured in milliliters.

Time frame: one hour after surgery

ArmMeasureValue (MEDIAN)
Total Laparoscopic Left Colectomy (Intracorporeal Anastomosis Group)the Blood Loss50 ml
Laparoscopic Assisted Left Colectomy (Extracorporeal Anastomosis Group)the Blood Loss50 ml
Secondary

the Incidence of Complications

It includes fever of unknown origin, bowel obstruction, anastomotic leakage, SSI, other incisional complications, respiratory complications, urinary complications, cardiovascular and cerebrovascular complications, diarrhea, chylous fistula, intraperitoneal hemorrhage, digestive hemorrhage, gastroparesis, and others (including bacteremia, cholecystitis, ion discharge, pancreatitis, and mental and behavioral abnormalities). Complications are graded according to the Clavien-Dindo classification.

Time frame: one month after surgery

Secondary

the Incision Length

The incision length is measured with an aseptic ruler at the end of the surgery, after the incision is sutured. It is measured in millimeters.

Time frame: one hour after surgery

Secondary

the Operating Time

It is defined as the period from cutting the skin to suturing the skin or doing enterostomy. It is measured in minutes

Time frame: one hour after surgery

Secondary

The Rate of Conversion to Open Surgery

It is defined as an abdominal incision larger than that necessary for specimen extraction.

Time frame: one hour after surgery

Secondary

Visual Analogue Scale/Score (VAS)

Pain severity was assessed 48 hours after the operation using a ruler about 10 cm long. The ruler is numbered from 0 to 10. 0-3 points indicate no to mild pain. 4-6 points represent moderate pain. 7-10 points stand for severe pain.

Time frame: 2 days after surgery

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026